Zagreb, Croatia

Tamara Cimbora Zovko

This inventor holds 1 USPTO granted patent. Top assignee: Rudjer Boskovic Institute. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamara Cimbora Zovko. Retrieved from https://idiyas.com/inventor/tamara-cimbora-zovko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tamara Cimbora Zovko: Innovator in Tumor Treatment

Introduction

Tamara Cimbora Zovko is a prominent inventor based in Zagreb, Croatia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for tumor treatment. Her innovative work has the potential to impact cancer therapy positively.

Latest Patents

Tamara holds a patent for "Analogues of 1,3-bis(4-nitrophenyl)triazenes, their pharmaceutically acceptable salts and N-acyl derivatives for tumour treatment." This invention refers to analogues that exhibit cytotoxicity at very low concentrations, ranging from IC0.22 to 12.8 µM, and demonstrate good solubility. These compounds can be utilized in treating tumor patients either as standalone drugs or in combination with other cytostatics.

Career Highlights

Tamara is affiliated with the Ruđer Bošković Institute, where she conducts her research and development work. Her dedication to advancing cancer treatment through innovative solutions is commendable.

Collaborations

Some of her notable coworkers include Maja Osmak and Slovenko Polanc, who contribute to her research endeavors.

Conclusion

Tamara Cimbora Zovko's work in developing novel compounds for tumor treatment showcases her commitment to improving cancer therapies. Her contributions are vital in the ongoing fight against cancer, and her innovative spirit continues to inspire others in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…